Literature DB >> 34189042

Acute myocarditis following administration of BNT162b2 vaccine.

Mhd Baraa Habib1, Tahseen Hamamyh2, Ahmed Elyas2, Mohammed Altermanini1, Mawahib Elhassan2.   

Abstract

The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.
© 2021 The Author(s).

Entities:  

Keywords:  BNT162b2; COVID-19; COVID-19, coronavirus disease 2019; Myocarditis; Pfizer-BioNTech; SARS-COV-2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Vaccine

Year:  2021        PMID： 34189042      PMCID： PMC8220234          DOI： 10.1016/j.idcr.2021.e01197

Source DB:  PubMed          Journal:  IDCases        ISSN： 2214-2509


  9 in total

1.  Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System.

Authors:  Riccardo Mei; Emanuel Raschi; Emanuele Forcesi; Igor Diemberger; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Int J Cardiol       Date:  2018-09-14       Impact factor: 4.164

Review 2.  Myocarditis.

Authors:  Sandeep Sagar; Peter P Liu; Leslie T Cooper
Journal:  Lancet       Date:  2011-12-18       Impact factor: 79.321

Review 3.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

4.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

5.  Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.

Authors:  Javier Bautista García; Pedro Peña Ortega; José Antonio Bonilla Fernández; Aridane Cárdenes León; Luis Ramírez Burgos; Eduardo Caballero Dorta
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2021-04-27

6.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Authors:  Andreas Greinacher; Thomas Thiele; Theodore E Warkentin; Karin Weisser; Paul A Kyrle; Sabine Eichinger
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

7.  Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection.

Authors:  Enrico Ammirati; Cristina Cavalotti; Angela Milazzo; Patrizia Pedrotti; Francesco Soriano; Jan W Schroeder; Nuccia Morici; Cristina Giannattasio; Maria Frigerio; Marco Metra; Paolo G Camici; Fabrizio Oliva
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-31

Review 8.  Myocarditis in COVID-19 patients: current problems.

Authors:  Donato Mele; Filippo Flamigni; Claudio Rapezzi; Roberto Ferrari
Journal:  Intern Emerg Med       Date:  2021-01-23       Impact factor: 5.472

9.  Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.

Authors:  Aristo Vojdani; Datis Kharrazian
Journal:  Clin Immunol       Date:  2020-05-24       Impact factor: 3.969
  9 in total
  20 in total

Review 1.  Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review.

Authors:  Maurish Fatima; Huzaifa Ahmad Cheema; Muhammad Huzaifa Ahmed Khan; Hafsa Shahid; Muhammad Saad Ali; Umer Hassan; Muhammad Wahaj Murad; Muhammad Aemaz Ur Rehman; Hareem Farooq
Journal:  Ann Med Surg (Lond)       Date:  2022-03-11

Review 2.  Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series.

Authors:  Dae Yong Park; Seokyung An; Amandeep Kaur; Saurabh Malhotra; Aviral Vij
Journal:  Clin Cardiol       Date:  2022-06-02       Impact factor: 3.287

Review 3.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

Review 4.  Myocarditis Following COVID-19 Vaccination: A Systematic Review of Case Reports.

Authors:  Benjamin J Behers; Genevieve A Patrick; Jared M Jones; Rachel A Carr; Brett M Behers; Julian Melchor; Delaney E Rahl; Timothy D Guerriero; Hongyu Zhang; Cuneyt Ozkardes; Nicholas D Thomas; Michael J Sweeney
Journal:  Yale J Biol Med       Date:  2022-06-30

Review 5.  Temporal Association Between the COVID-19 Ad26.COV2.S Vaccine and Acute Myocarditis: A Case Report and Literature Review.

Authors:  Imran Sulemankhil; Mohammad Abdelrahman; Smita I Negi
Journal:  Cardiovasc Revasc Med       Date:  2021-08-16

6.  Cardiovascular and haematological events post COVID-19 vaccination: A systematic review.

Authors:  Dana Al-Ali; Abdallah Elshafeey; Malik Mushannen; Hussam Kawas; Ameena Shafiq; Narjis Mhaimeed; Omar Mhaimeed; Nada Mhaimeed; Rached Zeghlache; Mohammad Salameh; Pradipta Paul; Moayad Homssi; Ibrahim Mohammed; Adeeb Narangoli; Lina Yagan; Bushra Khanjar; Sa'ad Laws; Mohamed B Elshazly; Dalia Zakaria
Journal:  J Cell Mol Med       Date:  2021-12-29       Impact factor: 5.310

7.  Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis.

Authors:  Adrija Hajra; Manasvi Gupta; Binita Ghosh; Kumar Ashish; Neelkumar Patel; Gaurav Manek; Devesh Rai; Jayakumar Sreenivasan; Akshay Goel; Carl J Lavie; Dhrubajyoti Bandyopadhyay
Journal:  Am J Cardiovasc Drugs       Date:  2021-11-24       Impact factor: 3.571

8.  Cardiac magnetic resonance characteristics of acute myocarditis occurring after mRNA-based COVID-19 vaccines immunization.

Authors:  Jaroslaw Meyer-Szary; Magdalena Bazgier; Paulina Lubocka; Karolina Dorniak; Robert Sabiniewicz
Journal:  Cardiol J       Date:  2021-11-17       Impact factor: 2.737

9.  Myocarditis following mRNA Covid-19 vaccination: A pooled analysis.

Authors:  Ioannis Bellos; Vasilios Karageorgiou; Dana Viskin
Journal:  Vaccine       Date:  2022-02-07       Impact factor: 4.169

Review 10.  Cardiovascular Complications of COVID-19 Vaccines.

Authors:  Runyu Liu; Junbing Pan; Chunxiang Zhang; Xiaolei Sun
Journal:  Front Cardiovasc Med       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.